Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniël C Overduin

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
JACC. Cardiovascular Interventions|February 14, 2024
What Oral Anticoagulant Is Best After TAVR: Vitamin K Antagonists or Direct Oral Anticoagulants?Jurriën M Ten Berg, Daniël C Overduin, Dirk-Jan van Ginkel
Journal of the American College of Cardiology|January 10, 2024
Best Oral Anticoagulant for Transcatheter Mitral Valve ReplacementJurriën M Ten Berg, Daniël C Overduin, Dirk Jan van Ginkel
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 16, 2026
Transcatheter aortic valve thrombosisMia Ravn Jacobsen, Daniël C Overduin, Rikke Sørensen, et al.
Journal of the American Heart Association|October 23, 2025
Sex Differences in Transcatheter Aortic Valve Implantation Outcomes in Patients on Oral Anticoagulants: A Popular PAUSE TAVI SubAnalysisKees H van Bergeijk, Daniël C Overduin, Constantijn S Venema, et al.
European Radiology|December 31, 2024
Coronary CTA and CT-FFR in trans-catheter aortic valve implantation candidates: a systematic review and meta-analysisLeonie M Becker, Joyce Peper, Dirk-Jan van Ginkel, et al.
JAMA Network Open|October 16, 2024
Upper- vs Lower-Extremity Secondary Access During Transcatheter Aortic Valve Implantation: A Randomized Clinical TrialGeert A A Versteeg, Maxim J P Rooijakkers, Kimberley I Hemelrijk, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|April 23, 2024
Upper extremity versus lower extremity for secondary access during transcatheter aortic valve implantation: rationale and design of the randomised TAVI XS trialMaxim J P Rooijakkers, Geert A A Versteeg, Kimberley I Hemelrijk, et al.
American Heart Journal|November 2, 2025
Routine versus selective protamine administration to reduce bleeding after TAVI: Rationale and design of the POPular ACE TAVI trialDaniël C Overduin, Dirk Jan van Ginkel, Christophe Dubois, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 13, 2026
Extremity Function After Transfemoral Transcatheter Aortic Valve Implantation: A TAVI XS Sub-StudyGeert A A Versteeg, Maxim J P Rooijakkers, Kimberley I Hemelrijk, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 4, 2025
Long-Term Durability of Transcatheter Aortic Valves in Patients With Bicuspid Aortic StenosisYuheng Jia, Annette Maznyczka, Mauro Boiago, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
JACC. Cardiovascular Interventions|February 14, 2024
What Oral Anticoagulant Is Best After TAVR: Vitamin K Antagonists or Direct Oral Anticoagulants?Jurriën M Ten Berg, Daniël C Overduin, Dirk-Jan van Ginkel
Journal of the American College of Cardiology|January 10, 2024
Best Oral Anticoagulant for Transcatheter Mitral Valve ReplacementJurriën M Ten Berg, Daniël C Overduin, Dirk Jan van Ginkel
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 16, 2026
Transcatheter aortic valve thrombosisMia Ravn Jacobsen, Daniël C Overduin, Rikke Sørensen, et al.
Journal of the American Heart Association|October 23, 2025
Sex Differences in Transcatheter Aortic Valve Implantation Outcomes in Patients on Oral Anticoagulants: A Popular PAUSE TAVI SubAnalysisKees H van Bergeijk, Daniël C Overduin, Constantijn S Venema, et al.
European Radiology|December 31, 2024
Coronary CTA and CT-FFR in trans-catheter aortic valve implantation candidates: a systematic review and meta-analysisLeonie M Becker, Joyce Peper, Dirk-Jan van Ginkel, et al.
JAMA Network Open|October 16, 2024
Upper- vs Lower-Extremity Secondary Access During Transcatheter Aortic Valve Implantation: A Randomized Clinical TrialGeert A A Versteeg, Maxim J P Rooijakkers, Kimberley I Hemelrijk, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|April 23, 2024
Upper extremity versus lower extremity for secondary access during transcatheter aortic valve implantation: rationale and design of the randomised TAVI XS trialMaxim J P Rooijakkers, Geert A A Versteeg, Kimberley I Hemelrijk, et al.
American Heart Journal|November 2, 2025
Routine versus selective protamine administration to reduce bleeding after TAVI: Rationale and design of the POPular ACE TAVI trialDaniël C Overduin, Dirk Jan van Ginkel, Christophe Dubois, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 13, 2026
Extremity Function After Transfemoral Transcatheter Aortic Valve Implantation: A TAVI XS Sub-StudyGeert A A Versteeg, Maxim J P Rooijakkers, Kimberley I Hemelrijk, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 4, 2025
Long-Term Durability of Transcatheter Aortic Valves in Patients With Bicuspid Aortic StenosisYuheng Jia, Annette Maznyczka, Mauro Boiago, et al.
Pageof 2